Two oral GLP-1s launched within five months of each other. Here’s the honest comparison, and how to find a program that offers the form you actually want.
For years, starting a GLP-1 meant accepting a weekly injection. That stopped being true in December 2025, when the FDA approved the Wegovy pill (oral semaglutide), the first GLP-1 pill for weight management. Four months later, Foundayo (orforglipron) followed: a once-daily pill from Eli Lilly that, unlike oral semaglutide, can be taken any time of day with no food or water restrictions.
Across the 22 LegitScript-certified programs we review, medication lineups differ significantly: some offer both semaglutide and tirzepatide with the ability to switch under supervision, some carry oral options, and pricing runs from $49 to $249 per month. Our comparison table shows each program’s medications side by side, and the quiz factors in your form preference.
Two oral GLP-1 medications are FDA-approved for weight management: the Wegovy pill (oral semaglutide, approved December 2025) and Foundayo (orforglipron, approved April 2026).[4] Both are once-daily.
Foundayo launched at $149/month for the lowest dose self-pay, with insured patients potentially paying as little as $25/month with a savings card. Oral Wegovy pricing varies by channel and insurance. Telehealth programs offering oral options range widely; compare before committing.
In clinical trials, the FDA-approved oral options produced meaningful weight loss alongside diet and exercise: an average of 13.6% with oral semaglutide 25 mg[2] and 11.2% with orforglipron 36 mg.[3] Individual results vary; a licensed clinician can advise which fits your situation.
Yes. Following the 2026 launches, oral GLP-1s are distributed through pharmacies and telehealth providers. A prescription after a medical evaluation is always required.
Match me to a program → Compare medications by program →
Educational content, not medical advice. Effectiveness figures reflect published clinical trials where medications were used alongside a reduced-calorie diet and exercise; individual results vary.[1][2][3] All GLP-1 medications require a prescription from a licensed clinician. Consult a doctor about which medication and form is appropriate for you.
About these figures: The clinical trial results cited on this page reflect the safety and efficacy of the FDA-approved brand-name medications that were studied (such as Wegovy®, Zepbound® and Foundayo™), used alongside a reduced-calorie diet and physical activity under clinical-trial conditions. Compounded medications do not undergo FDA evaluation for safety or effectiveness and were not studied in these trials; their efficacy and safety profiles may differ from the brand-name medications studied. Individual results vary. This information is educational and is not medical advice.
Price changes, new program reviews, and plain-English GLP-1 updates, straight to your inbox. Independent, and never sponsored by the programs we review.
By joining, you agree to receive emails from GLP One Guide. Unsubscribe anytime. We never sell your email. See our Privacy Policy.